{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:32:18Z","timestamp":1790775138081,"version":"4.1.0"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T00:00:00Z","timestamp":1563494400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T00:00:00Z","timestamp":1563494400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CHAFEA","award":["HP-ERN-SGA-2017 \u2013 769045"],"award-info":[{"award-number":["HP-ERN-SGA-2017 \u2013 769045"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13023-019-1064-y","type":"journal-article","created":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T13:03:00Z","timestamp":1563541380000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Diagnosis and management of individuals with Fetal Valproate Spectrum Disorder; a consensus statement from the European Reference Network for Congenital Malformations and Intellectual Disability"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9602-2321","authenticated-orcid":false,"given":"Jill","family":"Clayton-Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Bromley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Journel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Odent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verna","family":"Cuthbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latha","family":"Hackett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelo","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heli","family":"Malm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Westbom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund","family":"Ladusans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeet","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catrina","family":"Dyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Ashworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Hindley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma Arca","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myfanwy","family":"Rawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Turnpenny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,19]]},"reference":[{"issue":"2","key":"1064_CR1","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S0022-3476(80)80517-8","volume":"97","author":"B Dalens","year":"1980","unstructured":"Dalens B, Raynaud EJ, Gaulme J. Teratogenicity of valproic acid. J Pediatr. 1980;97(2):332\u20133.","journal-title":"J Pediatr"},{"key":"1064_CR2","unstructured":"New measures to avoid valproate exposure in pregnancy endorsed. European Medicines Agency. 2018: EMA\/145600\/2018 Available from. https:\/\/www.ema.europa.eu\/documents\/referral\/valproate-article-31-referral-new-measures-avoid-valproate-exposure-pregnancy-endorsed_en-0.pdf . Accessed 31 May 2018."},{"issue":"9566","key":"1064_CR3","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","volume":"369","author":"AG Marson","year":"2007","unstructured":"Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet. 2007;369(9566):1016\u201326.","journal-title":"Lancet."},{"key":"1064_CR4","first-page":"1282","volume":"2","author":"E Robert","year":"1982","unstructured":"Robert E, Guibaud P. Maternal valproic acid and congenital neural tube defects. Lancet. 1982;2:1282\u20133.","journal-title":"Lancet."},{"issue":"8359","key":"1064_CR5","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/S0140-6736(83)90656-6","volume":"2","author":"E Robert","year":"1983","unstructured":"Robert E, Rosa F. Valproate and birth defects. Lancet. 1983;2(8359):1142.","journal-title":"Lancet."},{"key":"1064_CR6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/ajmg.1320190308","volume":"19","author":"JH DiLiberti","year":"1984","unstructured":"DiLiberti JH, Farndon PA, Dennis NR, Curry CJR. The fetal valproate syndrome. Am Med Genet. 1984;19:473\u201381.","journal-title":"Am Med Genet"},{"issue":"8494","key":"1064_CR7","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/S0140-6736(86)91711-3","volume":"1","author":"D Lindhout","year":"1986","unstructured":"Lindhout D, Schmidt D. In utero exposure to valproate and neural tube defects. Lancet. 1986;1(8494):1392\u20133.","journal-title":"Lancet."},{"key":"1064_CR8","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S0022-3476(86)80949-0","volume":"108","author":"E Jager-Roman","year":"1986","unstructured":"Jager-Roman E, Deichl A, Jakob S, et al. Fetal growth, major malformations and minor anomalies in infants born to women receiving valproic acid. Pediatr. 1986;108:997\u20131004.","journal-title":"Pediatr."},{"key":"1064_CR9","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1017\/S0317167100026639","volume":"14","author":"C Huot","year":"1987","unstructured":"Huot C, Gauthier M, Lebel M, Larbrisseau A. Congenital malformations associated with maternal use of valproic acid. Can J Neurol Sci. 1987;14:290\u20133.","journal-title":"Can J Neurol Sci"},{"key":"1064_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/ajmg.1320290123","volume":"29","author":"HH Ardinger","year":"1988","unstructured":"Ardinger HH, Atkin JF, Blackston RD, et al. Verification of the fetal valproate syndrome phenotype. Am J Med Genet. 1988;29:171\u201385.","journal-title":"Am J Med Genet"},{"issue":"1","key":"1064_CR11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/JCP.0000000000000813","volume":"38","author":"N Patel","year":"2018","unstructured":"Patel N, Viguera AC, Baldessarini RJ. Mood stabilising Anticonvulsants, Spina Bifida and Folate Supplementation: Commentary. J Clin Psychopharmacol. 2018;38(1):7\u201310.","journal-title":"J Clin Psychopharmacol"},{"key":"1064_CR12","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1136\/jmg.32.9.724","volume":"32","author":"J Clayton-Smith","year":"1995","unstructured":"Clayton-Smith J, Donnai D. Fetal valproate syndrome. J Med Genet. 1995;32:724\u20137.","journal-title":"J Med Genet"},{"issue":"Suppl 5","key":"1064_CR13","first-page":"119","volume":"42","author":"JGC Omtzigt","year":"1992","unstructured":"Omtzigt JGC, Los FJ, Grobbee DE, et al. The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort. Neurology. 1992;42(Suppl 5):119\u201325.","journal-title":"Neurology."},{"key":"1064_CR14","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1600-0404.1992.tb04029.x","volume":"85","author":"D Battino","year":"1992","unstructured":"Battino D, Bimelli S, Caccamo ML, et al. Malformations in offspring of 305 epileptic women: a prospective study. Acta Neurol Scand. 1992;85:204\u20137.","journal-title":"Acta Neurol Scand"},{"key":"1064_CR15","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMoa0803531","volume":"360","author":"KJ Meador","year":"2009","unstructured":"Meador KJ, Baker GA, Browning N, et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med. 2009;360:1597\u2013605.","journal-title":"N Engl J Med"},{"issue":"2","key":"1064_CR16","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/epi.13632","volume":"58","author":"SV Thomas","year":"2017","unstructured":"Thomas SV, Jose M, Divakaran S, Sarma PS. Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: results from a pregnancy registry in South India. Epilepsia. 2017;58(2):274\u201381.","journal-title":"Epilepsia."},{"issue":"8","key":"1064_CR17","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.jocn.2004.05.003","volume":"11","author":"F Vajda","year":"2004","unstructured":"Vajda F, O\u2019Brien T, Hitchcock A, Graham J, Cook M, Lander C, Eadie MJ. Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy. J Clin Neurosci. 2004;11(8):854\u20138.","journal-title":"J Clin Neurosci"},{"issue":"6","key":"1064_CR18","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1212\/01.WNL.0000154516.43630.C5","volume":"64","author":"DF Wyszynski","year":"2005","unstructured":"Wyszynski DF, Nambisan M, Surve T, Alsdorf RM, Smith CR, Holmes LB. Antiepileptic Drug Pregnancy Registry. Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology. 2005;64(6):961\u20135.","journal-title":"Neurology"},{"key":"1064_CR19","first-page":"CD010224","volume":"11","author":"J Weston","year":"2016","unstructured":"Weston J, Bromley R, Jackson CF, Adab N, Clayton-Smith J, Greenhalgh J, Hounsome J, McKay AJ, Tudur Smith C, Marson AG. Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child. Cochrane Database Syst Rev. 2016;11:CD010224 Available from: https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD010224.pub2\/full . Accessed 20 Sept 2018.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1064_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eplepsyres.2008.04.022","volume":"81","author":"K Meador","year":"2008","unstructured":"Meador K, Reynolds M, Crean S, Fahrbach K, Probst C. Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts. Epilepsy Res. 2008;81(1):1\u201313.","journal-title":"Epilepsy Res"},{"issue":"4","key":"1064_CR21","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1212\/WNL.0000000000001182","volume":"84","author":"GA Baker","year":"2015","unstructured":"Baker GA, Bromley RL, Briggs M, Cheyne CP, Cohen MJ, Garc\u00eda-Fi\u00f1ana M, Gummery A, Kneen R, Loring DW, Mawer G, Meador KJ, Shallcross R, Clayton-Smith J, Liverpool and Manchester Neurodevelopment Group. IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study. Neurology. 2015;84(4):382\u201390.","journal-title":"Neurology."},{"key":"1064_CR22","first-page":"CD010236","volume":"10","author":"R Bromley","year":"2014","unstructured":"Bromley R, Weston J, Adab N, Greenhalgh J, Sanniti A, McKay AJ, Tudur Smith C, Marson A. Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child (review). Cochrane Database Syst Rev. 2014;10:CD010236 Available from. https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD010236.pub2\/full . Accessed 20 Sept 2018.","journal-title":"Cochrane Database Syst Rev"},{"key":"1064_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ntt.2016.01.001","volume":"54","author":"U Deshmukh","year":"2016","unstructured":"Deshmukh U, Adams J, Macklin EA, Dhillon R, McCarthy KD, Dworetzky B, Klein A, Holmes LB. Behavioural outcomes in children exposed prenatally to lamotrigine, valproate or carbamazepine. Neurotoxicol Teratol. 2016;54:5\u201314.","journal-title":"Neurotoxicol Teratol"},{"key":"1064_CR24","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1017\/S0012162205001076","volume":"47","author":"AD Rasalam","year":"2005","unstructured":"Rasalam AD, Hailey H, Williams JHG, Moore SJ, Turnpenny PD, Lloyd DJ, Dean JC. Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Dev Med Child Neurol. 2005;47:551\u20135.","journal-title":"Dev Med Child Neurol"},{"issue":"16","key":"1064_CR25","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1001\/jama.2013.2270","volume":"309","author":"J Christensen","year":"2013","unstructured":"Christensen J, Koops Gr\u00f8nborg T, S\u00f8rensen M, Schendel D, Parner ET, Pedersen LH, Vestergaard M. Prenatal valproate exposure and risk of autism Spectrum disorders and childhood autism. JAMA. 2013;309(16):1696\u2013703.","journal-title":"JAMA."},{"issue":"6","key":"1064_CR26","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/jnnp-2012-304270","volume":"84","author":"RL Bromley","year":"2013","unstructured":"Bromley RL, Mawer GE, Briggs M, Cheyne C, Clayton-Smith J, Garc\u00eda-Fi\u00f1ana M, Kneen R, Lucas S, Shallcross R, Baker GA. Liverpool and Manchester neurodevelopment group. The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry. 2013;84(6):637\u201343.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1064_CR27","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1136\/jmg.37.7.489","volume":"37","author":"SJ Moore","year":"2000","unstructured":"Moore SJ, Turnpenny P, Quinn A, et al. A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet. 2000;37:489\u201397.","journal-title":"J Med Genet"},{"issue":"12","key":"1064_CR28","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1136\/jnnp-2017-317368","volume":"89","author":"MO Kinney","year":"2018","unstructured":"Kinney MO, Morrow J, Patterson CP, Campbell E, Russell A, Smithson HW, Parsons L, Morrison PJ, Bromley R, Liggan B, Delanty N, Irwin B, Hunt SJ, Craig J. Changing antiepilepsy drug-prescribing trends in women with epilepsy in the UK and Ireland and the impact on major congenital malformations. J Neurol Neurosurg Psychiatry. 2018;89(12):1320\u20133.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1064_CR29","unstructured":"EURORDIS (2009) The Voice of 12 000 Patients. Experiences and expectations of rare disease patients on diagnosis and care in Europe. EURORDIS, Paris. Available from. http:\/\/www.eurordis.org\/IMG\/pdf\/voice_12000_patients\/EURORDISCARE_FULLBOOKr.pdf . Accessed 18 Jan 2018."},{"key":"1064_CR30","unstructured":"Protocol National de Diagnostic et de Soin Embryo-F\u0153topathie au Valproate. Centre de r\u00e9f\u00e9rence Anomalies du D\u00e9veloppement et Syndromes Malformatifs de l\u2019Ouest France. Fili\u00e8res ANDDI-Rares et D\u00e9fiScience. Avaialable from. https:\/\/www.has-sante.fr\/portail\/upload\/docs\/application\/pdf\/2017-03\/dir1\/pnds_-_embryo-foetopathie_au_valproate.pdf . Accessed 1 Sept 2017."},{"key":"1064_CR31","unstructured":"Haute Autorite de Sante Practice Guidelines Formal Consensus Method. Avaialable from. https:\/\/www.has-sante.fr\/portail\/jcms\/c_2040454\/fr\/sbpp2-methodologie-d-elaboration-des-recommandations . Accessed 22 Mar 2018."},{"issue":"18","key":"1064_CR32","doi-asserted-by":"publisher","first-page":"E839","DOI":"10.1503\/cmaj.091716","volume":"182","author":"MC Brouwers","year":"2010","unstructured":"Brouwers MC, Kho ME, , Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J,Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L, AGREE Next Steps Consortium. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010; 182(18): E839\u2013E842. https:\/\/doi.org\/10.1503\/cmaj.091716 .","journal-title":"CMAJ"},{"key":"1064_CR33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1136\/jmg.39.4.243","volume":"39","author":"H Dolk","year":"2002","unstructured":"Dolk H, McElhaton P. Assessing epidemiological evidence for the teratogenic effects of anticonvulsant medications. J Med Genet. 2002;39:243\u20134.","journal-title":"J Med Genet"},{"key":"1064_CR34","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","volume":"77","author":"J Morrow","year":"2006","unstructured":"Morrow J, Russell A, Guthrie E, Parsons L, Robertson I, Waddell R, Irwin B, McGivern RC, Morrison PJ, Craig J. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK epilepsy and pregnancy register. J Neurol Neurosurg Psychiatry. 2006;77:193\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1064_CR35","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1136\/jmg.39.4.251","volume":"39","author":"JCS Dean","year":"2002","unstructured":"Dean JCS, Hailey H, Moore SJ, et al. Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J Med Genet. 2002;39:251\u20139.","journal-title":"J Med Genet"},{"key":"1064_CR36","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1136\/jmg.24.11.692","volume":"24","author":"RM Winter","year":"1987","unstructured":"Winter RM, Donnai D, Burn J, Tucker SM. Fetal valproate syndrome: is there a recognisable phenotype? J Med Genet. 1987;24:692\u20135.","journal-title":"J Med Genet"},{"issue":"3","key":"1064_CR37","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S1474-4422(12)70323-X","volume":"12","author":"K Meador","year":"2013","unstructured":"Meador K, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J, Kalayjian L, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW, NEAD Study Group. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol. 2013;12(3):244\u201352.","journal-title":"Lancet Neurol"},{"key":"1064_CR38","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/S0140-6736(82)90018-6","volume":"2","author":"T Bjerkedal","year":"1982","unstructured":"Bjerkedal T, Czeizel A, Goujard J, Kallen B, Mastroiacova P, Nevin N, Oakley G Jr, Robert E. Valproic acid and spina bifida. Lancet. 1982;2:1096.","journal-title":"Lancet."},{"key":"1064_CR39","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/1096-8628(20010115)98:2<168::AID-AJMG1026>3.0.CO;2-O","volume":"98","author":"C Kozma","year":"2001","unstructured":"Kozma C. Valproic acid Embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature. Am J Med Genet. 2001;98:168\u201375.","journal-title":"Am J Med Genet"},{"key":"1064_CR40","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1469-8749.1994.tb11858.x","volume":"36","author":"AL Christianson","year":"1994","unstructured":"Christianson AL, Chesler N, Kromberg JGR. Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs. Dev Med Child Neurol. 1994;36:357\u201369.","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"1064_CR41","doi-asserted-by":"publisher","first-page":"F207","DOI":"10.1136\/archdischild-2015-308278","volume":"101","author":"A Jackson","year":"2015","unstructured":"Jackson A, Bromley R, Morrow J, Irwin B, Clayton-Smith J. In utero exposure to valproate increases the risk of isolated cleft palate. Arch Dis Child Fetal Neonatal Ed. 2015;101(3):F207\u201311.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"1064_CR42","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000263924","volume":"9","author":"B Langer","year":"1994","unstructured":"Langer B, Haddad J, Gasser B, Maubert M, Schlaeder G. Isolated fetal bilateral radial ray reduction associated with valproic acid usage. Fetal Diagn Ther. 1994;9:155\u20138.","journal-title":"Fetal Diagn Ther"},{"key":"1064_CR43","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/BF01954134","volume":"151","author":"IM Buntinx","year":"1992","unstructured":"Buntinx IM. Preaxial polydactyly in the fetal valproate syndrome. Eur J Pediatr. 1992;151:919\u201320.","journal-title":"Eur J Pediatr"},{"key":"1064_CR44","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/pd.1970131005","volume":"13","author":"R Sharony","year":"1993","unstructured":"Sharony R, Garber A, Viskochil D, et al. Preaxial ray reduction defects as part of valproic acid embryofetopathy. Prenat Diagn. 1993;13:909\u201318.","journal-title":"Prenat Diagn"},{"issue":"4","key":"1064_CR45","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/BF02106290","volume":"149","author":"A Verloes","year":"1990","unstructured":"Verloes A, Frikiche A, Gremillet C, et al. Proximal phocomelia and radial ray aplasia in fetal valproic syndrome. Eur J Pediatr. 1990;149(4):266\u20137.","journal-title":"Eur J Pediatr"},{"key":"1064_CR46","doi-asserted-by":"publisher","first-page":"3495910","DOI":"10.1155\/2016\/3495910","volume":"2016","author":"M Goyal","year":"2016","unstructured":"Goyal M, Gupta A, Sharma M, Mathur P, Bansal N. Fetal valproate syndrome with limb defects: an Indian case report. Case Reports Pediatrics. 2016;2016:3495910. https:\/\/doi.org\/10.1155\/2016\/3495910 .","journal-title":"Case Reports Pediatrics"},{"key":"1064_CR47","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S0161-6420(02)00959-4","volume":"106","author":"SJ Glover","year":"2002","unstructured":"Glover SJ, Quinn AG, Barter P, Hart J, Moore SJ, Dean JCS, FRCP, Turnpenny PD. Ophthalmic findings in fetal anticonvulsant syndrome(s). Ophthalmology. 2002;106:942\u20137.","journal-title":"Ophthalmology."},{"issue":"1","key":"1064_CR48","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/MCD.0000000000000018","volume":"23","author":"KH Shah","year":"2014","unstructured":"Shah KH, Shailaja S, Girisha KM. Is coloboma a feature of fetal valproate syndrome? Clin Dysmorphol. 2014;23(1):24\u20135.","journal-title":"Clin Dysmorphol"},{"issue":"2","key":"1064_CR49","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/MCD.0000000000000028","volume":"23","author":"A Jackson","year":"2014","unstructured":"Jackson A, Fryer A, Clowes V, Clayton-Smith J. Ocular coloboma and fetal valproate syndrome: four further cases and a hypothesis for aetiology. Clin Dysmorphol. 2014;23(2):74\u20135.","journal-title":"Clin Dysmorphol"},{"issue":"3","key":"1064_CR50","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3109\/14767058.2010.501120","volume":"24","author":"H Ozcan","year":"2011","unstructured":"Ozcan H, Cetinkaya M, Koksal N, Yapici S. Severe fetal valproate syndrome: combination of complex cardiac defect, multicystic dysplastic kidney and trigonocephaly. J Matern Fetal Neonatal Med. 2011;24(3):521\u20134.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"1064_CR51","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1212\/WNL.59.4.630","volume":"59","author":"H Malm","year":"2002","unstructured":"Malm H, Kajantie E, Kivirikko S, K\u00e4\u00e4ri\u00e4inen H, Peippo M, Somer M. Valproate embryopathy in three sets of siblings: further proof of hereditary susceptibility. Neurology. 2002;59:630\u20133.","journal-title":"Neurology."},{"key":"1064_CR52","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/S1059-1311(02)00135-8","volume":"11","author":"G Mawer","year":"2002","unstructured":"Mawer G, Clayton-Smith J, Coyle H, Kini U. Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate. Seizure. 2002;11:512\u20138.","journal-title":"Seizure."},{"key":"1064_CR53","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1053\/seiz.2000.0392","volume":"9","author":"JCS Dean","year":"2000","unstructured":"Dean JCS, Moore SJ, Turnpenny PD. Developing diagnostic criteria for the fetal anticonvulsant syndromes. Seizure. 2000;9:233\u20134.","journal-title":"Seizure"},{"key":"1064_CR54","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/j.1651-2227.1994.tb13143.x","volume":"83","author":"A Hubert","year":"1994","unstructured":"Hubert A, Bonneau D, Couet D, Berthier M, Oriot D, Larregue M. Aplasia cutis congenita of the scalp in an infant exposed to valproic acid in utero. Acta Paediatr. 1994;83:789\u201390.","journal-title":"Acta Paediatr"},{"key":"1064_CR55","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/978-1-4613-2189-7_2","volume-title":"Handbook of behavioral teratology","author":"CV Vorhees","year":"1986","unstructured":"Vorhees CV. Principles of behavioral teratology. In: Riley EP, Vorhees C, editors. Handbook of behavioral teratology. New York: Plenum Press; 1986. p. 23\u201348."},{"key":"1064_CR56","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ntt.2018.11.003","volume":"71","author":"R Bromley","year":"2018","unstructured":"Bromley R, Clayton-Smith J, Wood A. Intellectual functioning in clinically confirmed fetal valproate syndrome. Neurotoxicol Teratol. 2018;71:16\u201321. https:\/\/doi.org\/10.1016\/j.ntt.2018.11.003 .","journal-title":"Neurotoxicol Teratol"},{"key":"1064_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1355617710001359","volume":"17","author":"C Nadebaum","year":"2011","unstructured":"Nadebaum C, Anderson V, Vajda F, Reutens D, Barton S, Wood A. The Australian brain and cognition and anti- epileptic drugs study: IQ in school-aged children exposed to sodium valproate and polytherapy. J Int Neuropsychol Soc. 2011;17:1\u201310.","journal-title":"J Int Neuropsychol Soc"},{"key":"1064_CR58","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.yebeh.2016.10.014","volume":"66","author":"S Kasradze","year":"2017","unstructured":"Kasradze S, Gogatishvili N, Lomidze G, Ediberidze T, Lazariashvili M, Khomeriki K, et al. Cognitive functions in children exposed to antiepileptic drugs in utero - study in Georgia. Epilepsy Behav. 2017;66:105\u201312.","journal-title":"Epilepsy Behav"},{"key":"1064_CR59","doi-asserted-by":"publisher","first-page":"F90","DOI":"10.1136\/adc.2004.067421","volume":"91","author":"U Kini","year":"2006","unstructured":"Kini U, Adab N, Vinten J, Fryer A, Clayton-Smith J, Liverpool and Manchester Neurodevelopmental Study Group. Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes. Arch Dis Child Fetal Neonatal Ed. 2006;91:F90\u20135.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"3","key":"1064_CR60","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1177\/0706743718777398","volume":"64","author":"Jasmine M. Brown","year":"2018","unstructured":"Brown JM, Bland R, Jonsson E, Greenshaw AJ. The standardization of diagnostic criteria for fetal alcohol Spectrum disorder (FASD): implications for research, clinical practice and population health. Can J Psychiatr. 2018. https:\/\/doi.org\/10.1177\/0706743718777398 .","journal-title":"The Canadian Journal of Psychiatry"},{"key":"1064_CR61","unstructured":"Valproate Use By Women And Girls.2018; Available from. https:\/\/www.gov.uk\/guidance\/valproate-use-by-women-and-girls . Accessed 20 Mar 2018."},{"issue":"3","key":"1064_CR62","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1093\/brain\/awt368","volume":"137","author":"AL Peljto","year":"2014","unstructured":"Peljto AL, Barker-Cummings C, Vasoli VM, Leibson CL, Hauser WA, Buchhalter JR, Ottman R. Familial risk of epilepsy: a population-based study. Brain. 2014;137(3):795\u2013805.","journal-title":"Brain."},{"key":"1064_CR63","unstructured":"Royal College of Obstetricians Green Top Guideline Number 68 .Epilepsy in Pregnancy. 2016. Avaialable from https:\/\/www.rcog.org.uk\/globalassets\/documents\/guidelines\/green-top-guidelines\/gtg68_epilepsy.pdf . Accessed 31 May 2018."},{"issue":"8","key":"1064_CR64","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/pds.1975","volume":"19","author":"J Jentink","year":"2010","unstructured":"Jentink J, Bakker MK, Nijenhuis CM, Wilffert B, de Jong-van den Berg LT. Does folic acid use decrease the risk for spina bifida after in utero exposure to valproic acid? Pharmacoepidemiol Drug Saf. 2010;19(8):803\u20137.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"1064_CR65","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1111\/j.1528-1167.2009.02130.x","volume":"50","author":"CL Harden","year":"2009","unstructured":"Harden CL, Pennell PB, Koppel BS, Hovinga CA, Gidal B, Meador KJ, Hopp J, Ting TY, Hauser WA, Thurman D, Kaplan PW, Robinson JN, French JA, Wiebe S, Wilner AN, Vazquez B, Holmes L, Krumholz A, Finnell R, Shafer PO, Le Guen CL, American Academy of Neurology, American Epilepsy Society. Management issues for women with epilepsy--focus on pregnancy (an evidence-based review): III. Vitamin K, folic acid, blood levels, and breast-feeding: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia. 2009;50(5):1247\u201355.","journal-title":"Epilepsia"},{"key":"1064_CR66","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3945\/jn.115.223644","volume":"146","author":"K Pentieva","year":"2016","unstructured":"Pentieva K, Selhub J, Paul L, Molloy AM, McNulty B, Ward M, Marshall B, Dornan J, Reilly R, Parle-McDermott A, Bradbury I, Ozaki M, Scott JM, McNulty H. Evidence from a randomized trial that exposure to supplemental folic acid at recommended levels during pregnancy does not Lead to increased Unmetabolized folic acid concentrations in maternal or cord blood. J Nutr. 2016;146:494\u2013500.","journal-title":"J Nutr"},{"key":"1064_CR67","unstructured":"Newborn and infant physical examination screening programme handbook. Public Health England, updated April 2008. Available from: https:\/\/www.gov.uk\/government\/publications\/newborn-and-infant-physical-examination-programme-handbook . Accessed 31 May 2018."},{"issue":"10","key":"1064_CR68","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/archdischild-2012-303564","volume":"98","author":"M McGovern","year":"2013","unstructured":"McGovern M, Mulligan S, Carney O, Wall D, Moylett E. Ultrasound investigation of sacral dimples and other stigmata of spinal dysraphism. Arch Dis Child. 2013;98(10):784\u20136.","journal-title":"Arch Dis Child"},{"issue":"2","key":"1064_CR69","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00381-017-3638-0","volume":"34","author":"E Ausili","year":"2018","unstructured":"Ausili E, Maresca G, Massimi L, Morgante L, Romagnoli C, Rendeli C. Occult spinal dysraphisms in newborns with skin markers: role of ultrasonography and magnetic resonance imaging. Childs Nerv Syst. 2018;34(2):285\u201391.","journal-title":"Childs Nerv Syst"},{"key":"1064_CR70","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1136\/adc.69.3_Spec_No.288","volume":"69","author":"E Thisted","year":"1993","unstructured":"Thisted E, Ebbeson F. Malformations, withdrawal manifestations and hypoglycaemia after exposure to valproate in utero. Arch Dis Child. 1993;69:288\u201391.","journal-title":"Arch Dis Child"},{"issue":"11","key":"1064_CR71","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1001\/jamaneurol.2013.4290","volume":"70","author":"G Veiby","year":"2013","unstructured":"Veiby G, Engelsen BA, Gilhus NE. Early child development and exposure to antiepileptic drugs prenatally and through breastfeeding: a prospective cohort study on children of women with epilepsy. JAMA Neurol. 2013;70(11):1367\u201374.","journal-title":"JAMA Neurol"},{"key":"1064_CR72","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.seizure.2015.02.013","volume":"28","author":"G Veiby","year":"2015","unstructured":"Veiby G, Bj\u00f8rk M, Engelsen BA, Gilhus NE. Epilepsy and recommendations for breastfeeding. Seizure. 2015;28:57\u201365.","journal-title":"Seizure."},{"key":"1064_CR73","first-page":"3","volume":"17","author":"MC Thorne","year":"2016","unstructured":"Thorne MC, Garetz SL. Laryngomalacia: review and summary of current clinical practice in 2015. Paediatr Respir Rev. 2016;17:3\u20138.","journal-title":"Paediatr Respir Rev"},{"issue":"9","key":"1064_CR74","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1111\/j.1528-1167.2009.02147.x","volume":"50","author":"G Veiby","year":"2009","unstructured":"Veiby G, Daltveit AK, Engelsen BA, Gilhus NE. Pregnancy, delivery, and outcome for the child in maternal epilepsy. Epilepsia. 2009;50(9):2130\u20139.","journal-title":"Epilepsia."},{"issue":"4","key":"1064_CR75","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1302\/0301-620X.76B4.8027137","volume":"76","author":"NS Broughton","year":"1994","unstructured":"Broughton NS, Graham G, Menelaus MB. The high incidence of foot deformity in patients with high-level spina bifida. J Bone Joint Surg Br. 1994;76(4):548\u201350.","journal-title":"J Bone Joint Surg Br"},{"key":"1064_CR76","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/pd.1948","volume":"28","author":"M Valentin","year":"2008","unstructured":"Valentin M, Ducarme G, Yver C, Vuillard E, Belarbi N, Renier D, Luton D. Trigonocephaly and valproate: a case report and review of the literature. Prenat Diagn. 2008;28:259\u201361.","journal-title":"Prenat Diagn"},{"issue":"5","key":"1064_CR77","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3171\/jns.2001.95.5.0778","volume":"95","author":"E Lajeunie","year":"2001","unstructured":"Lajeunie E, Barcik U, Thorne JA, El Ghouzzi V, Bourgeois M, Renier D. Craniosynostosis and fetal exposure to sodium valproate. J Neurosurg. 2001;95(5):778\u201382.","journal-title":"J Neurosurg"},{"key":"1064_CR78","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/j.1440-1754.2007.01176.x","volume":"43","author":"ZI Carrim","year":"2007","unstructured":"Carrim ZI, McKay L, Sidiki SS, Lavy TE. Early intervention for the ocular and neurodevelopmental sequelae of fetal valproate syndrome. J Paediatr Child Health. 2007;43:643\u20135.","journal-title":"J Paediatr Child Health"},{"key":"1064_CR79","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jpeds.2010.07.021","volume":"158","author":"B Smits-Engelsman","year":"2011","unstructured":"Smits-Engelsman B, Klerks M, Kirby A. Beighton score: a valid measure for generalized hypermobility in children. J Pediatr. 2011;158:119\u201323.","journal-title":"J Pediatr"},{"issue":"20","key":"1064_CR80","doi-asserted-by":"publisher","first-page":"e10655","DOI":"10.1097\/MD.0000000000010655","volume":"97","author":"RL Hsieh","year":"2018","unstructured":"Hsieh RL, Peng HL, Lee WC. Short-term effects of customized arch support insoles on symptomatic flexible flatfoot in children: A randomized controlled trial. Medicine (Baltimore). 2018;97(20):e10655. https:\/\/doi.org\/10.1097\/MD.0000000000010655 .","journal-title":"Medicine (Baltimore)"},{"key":"1064_CR81","unstructured":"National Health Check For People With Learning Disabilities Template. Available from. https:\/\/www.england.nhs.uk\/wp...\/05\/nat-elec-health-check-ld-clinical-template.pdf Accessed 15 Sept 2018."},{"key":"1064_CR82","unstructured":"Valproate banned without the pregnancy prevention programme. MHRA Press Release April 2018. Available from. https:\/\/www.gov.uk\/government\/news\/valproate-banned-without-the-pregnancy-prevention-programme . Accessed 24 Apr 2018."},{"key":"1064_CR83","unstructured":"Booklet for patients prescribed sodium valproate. Available from. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/708849\/123683_Valproate_Patient_Booklet_DR18.pdf . Accessed 1 Oct 2018."},{"issue":"8","key":"1064_CR84","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1111\/apa.14290","volume":"107","author":"LA Henry","year":"2018","unstructured":"Henry LA, Cassidy T, McLaughlin M, Pentieva K, McNulty H, Walsh CP, Lees-Murdock D. Folic acid supplementation throughout pregnancy: psychological developmental benefits for children. Acta Paediatr. 2018;107(8):1370\u20138.","journal-title":"Acta Paediatr"},{"issue":"2","key":"1064_CR85","doi-asserted-by":"publisher","DOI":"10.4155\/fsoa-2015-0015","volume":"2","author":"N Moussa","year":"2016","unstructured":"Moussa N, Nasab SH, Haidar ZA, Blackwell SC, Sibai BM. Folic acid supplementation: what is new? Fetal, obstetric, long-term benefits and risks. Future Sci OA. 2016;2(2):FSO116. https:\/\/doi.org\/10.4155\/fsoa-2015-0015 .","journal-title":"Future Sci OA"},{"issue":"8","key":"1064_CR86","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/pds.1975","volume":"19","author":"J Jentink","year":"2010","unstructured":"Jentink J, Bakker MK, Nijenhuis CM, Wilffert B, de Jong-van den Berg LT. Does folic acid use decrease the risk for spina bifida after in utero exposure to valproic acid? Pharmacoepidemiol Drug Saf. 2010;19(8):803\u20137.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1064_CR87","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1474-4422(11)70107-7","volume":"10","author":"T Tomson","year":"2011","unstructured":"Tomson T, Battino D, Bonizzoni E, et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol. 2011;10:609\u201317.","journal-title":"Lancet Neurol"},{"issue":"23","key":"1064_CR88","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1056\/NEJMoa0907328","volume":"362","author":"J Jentink","year":"2010","unstructured":"Jentink J, Loane MA, Dolk H, Barisic I, Garne E, Morris JK, de Jong-van den Berg LT, EUROCAT Antiepileptic Study Working Group. Valproic acid monotherapy in pregnancy and major congenital malformations. NEJM. 2010;362(23):2185\u201393.","journal-title":"NEJM"},{"issue":"4","key":"1064_CR89","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.yebeh.2012.05.010","volume":"24","author":"PB Pennell","year":"2012","unstructured":"Pennell PB, Klein AM, Browning N, Baker GA, Clayton-Smith J, Kalayjian LA, Liporace JD, Privitera M, Crawford T, Loring DW, Meador KJ, NEAD Study Group. Differential effects of antiepileptic drugs on neonatal outcomes. Epilepsy Behav. 2012;24(4):449\u201356.","journal-title":"Epilepsy Behav"},{"issue":"5","key":"1064_CR90","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s40264-013-0052-8","volume":"36","author":"M Artama","year":"2013","unstructured":"Artama M, Gissler M, Malm H, Ritvanen A. Effects of maternal epilepsy and antiepileptic drug use during pregnancy on perinatal health in offspring: nationwide, retrospective cohort study in Finland. Drug Saf. 2013;36(5):359\u201369.","journal-title":"Drug Saf"},{"issue":"9","key":"1064_CR91","doi-asserted-by":"publisher","first-page":"e007425","DOI":"10.1136\/bmjopen-2014-007425","volume":"5","author":"J Christensen","year":"2015","unstructured":"Christensen J, Pedersen HS, Kjaersgaard MIS, Parner ET, Vestergaard M, S\u00f8rensen MJ, et al. Apgar-score in children prenatally exposed to antiepileptic drugs: a population-based cohort study. BMJ Open. 2015;5(9):e007425. https:\/\/doi.org\/10.1136\/bmjopen-2014-007425 .","journal-title":"BMJ Open"},{"issue":"2","key":"1064_CR92","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/00004714-199804000-00009","volume":"18","author":"KL Wisner","year":"1998","unstructured":"Wisner KL, Perel J. Serum levels of valproate and carbamazepine in breastfeeding mother-infant pairs. J Clin Psychopharmacol. 1998;18(2):167\u20139.","journal-title":"J Clin Psychopharmacol"},{"issue":"8","key":"1064_CR93","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1001\/jamapediatrics.2014.118","volume":"168","author":"KJ Meador","year":"2014","unstructured":"Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW. Neurodevelopmental effects of antiepileptic drugs (NEAD) study group. Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years. JAMA Pediatr. 2014;168(8):729\u201336.","journal-title":"JAMA Pediatr"},{"key":"1064_CR94","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/jmg.35.1.83","volume":"36","author":"CN Mo","year":"1998","unstructured":"Mo CN, Ladusans EJ. Anomalous right pulmonary artery origins in association with the fetal valproate syndrome. J Med Genet. 1998;36:83\u20134.","journal-title":"J Med Genet"},{"issue":"1","key":"1064_CR95","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/PL00011963","volume":"24","author":"S Ceylan","year":"2001","unstructured":"Ceylan S, Duru S, Ceylan S. Valproic acid sodium-induced spina bifida occulta in the rat. Neurosurg Rev. 2001;24(1):31\u20134.","journal-title":"Neurosurg Rev"},{"key":"1064_CR96","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/BF01954275","volume":"154","author":"T Boussemart","year":"1995","unstructured":"Boussemart T, Bonneau D, Levard G, Berthier M, Oriot D. Omphalocele in a newborn baby exposed to sodium valproate in utero. Eur J Pediatr. 1995;154:220\u20131.","journal-title":"Eur J Pediatr"},{"key":"1064_CR97","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1093\/brain\/awr103","volume":"134","author":"V Anderson","year":"2011","unstructured":"Anderson V, Spencer-Smith M, Wood A. Do children really recover better? Neurobehavioural plasticity after early brain insult. Brain. 2011;134:2197\u2013221.","journal-title":"Brain."},{"key":"1064_CR98","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/jnnp.70.1.15","volume":"70","author":"N Adab","year":"2001","unstructured":"Adab N, Jacoby A, Smith D, Chadwick D. Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry. 2001;70:15\u201321.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"1064_CR99","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1136\/adc.2009.176990","volume":"96","author":"C Cummings","year":"2011","unstructured":"Cummings C, Stewart M, Stevenson M, Morrow J, Nelson J. Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine. Arch Dis Child. 2011;96(7):643\u20137.","journal-title":"Arch Dis Child"},{"issue":"1","key":"1064_CR100","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.yebeh.2008.01.010","volume":"13","author":"SV Thomas","year":"2008","unstructured":"Thomas SV, Ajaykumar B, Sindhu K, Nair MKC, George B, Sarma PS. Motor and mental development of infants exposed to antiepileptic drugs in utero. Epilepsy Behav. 2008;13(1):229\u201336.","journal-title":"Epilepsy Behav"},{"issue":"3","key":"1064_CR101","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.eplepsyres.2005.06.001","volume":"65","author":"K Eriksson","year":"2005","unstructured":"Eriksson K, Viinikainen K, M\u00f6nkk\u00f6nen A, Aiki\u00e4 M, Nieminen P, Heinonen S, K\u00e4lvi\u00e4inen R. Children exposed to valproate in utero--population based evaluation of risks and confounding factors for long-term neurocognitive development. Epilepsy Res. 2005;65(3):189\u2013200.","journal-title":"Epilepsy Res"},{"key":"1064_CR102","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/brain\/awq352","volume":"134","author":"KJ Meador","year":"2011","unstructured":"Meador KJ, Baker GA, Browning N, Cohen MJ, Clayton-Smith J, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW, NEAD Study Group. Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age. Brain. 2011;134:396\u2013404.","journal-title":"Brain."},{"issue":"6","key":"1064_CR103","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1212\/01.WNL.0000154514.82948.69","volume":"64","author":"J Vinten","year":"2005","unstructured":"Vinten J, Adab N, Kini U, Gorry J, Gregg J, Baker GA, Liverpool and Manchester Neurodevelopment Study Group. Neuropsychological effects of exposure to anticonvulsant medication in utero. Neurology. 2005;64(6):949\u201354.","journal-title":"Neurology."},{"issue":"6","key":"1064_CR104","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1001\/jamaneurol.2017.5035","volume":"75","author":"LS Elkjaer","year":"2018","unstructured":"Elkjaer LS, Bech BH, Sun Y, Laursen TM, Christensen J. Association between prenatal valproate exposure and performance on standardized language and mathematics tests in school-aged children. JAMA Neurol. 2018;75(6):663\u201371.","journal-title":"JAMA Neurol"},{"issue":"9531","key":"1064_CR105","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0140-6736(06)69041-7","volume":"368","author":"G Baird","year":"2006","unstructured":"Baird G, Simonoff E, Pickles A, Chandler S, Loucas T, Meldrum D, Charman T. Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the special needs and autism project (SNAP). Lancet. 2006;368(9531):210\u20135.","journal-title":"Lancet."},{"issue":"1","key":"1064_CR106","doi-asserted-by":"publisher","first-page":"e186606","DOI":"10.1001\/jamanetworkopen.2018.6606","volume":"2","author":"J Christensen","year":"2019","unstructured":"Christensen J, Pedersen L, Sun Y, Werenberg Dreier J, Brikell I, Dalsgaard S. Association of Prenatal Exposure to valproate and other antiepileptic Rrugs with risks for attention-deficit\/hyperactivity disorder in offspring. JAMA Netw Open. 2019;2(1):e186606. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.6606 .","journal-title":"JAMA Netw Open"},{"issue":"7","key":"1064_CR107","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/epi.13007","volume":"56","author":"AG Wood","year":"2015","unstructured":"Wood AG, Nadebaum C, Anderson V, Reutens D, Barton S, O\u2019Brien TJ, Vajda F. Prospective assessment of autism traits in children exposed to antiepileptic drugs during pregnancy. Epilepsia. 2015;56(7):1047\u201355.","journal-title":"Epilepsia"},{"key":"1064_CR108","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/sj.npp.1300518","volume":"30","author":"T Schneider","year":"2005","unstructured":"Schneider T, Przew\u0142ocki R. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology. 2005;30:80\u20139.","journal-title":"Neuropsychopharmacology."},{"issue":"12","key":"1064_CR109","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3390\/brainsci7120159","volume":"7","author":"M Mag\u00e1n-Maganto","year":"2017","unstructured":"Mag\u00e1n-Maganto M, Bejarano-Mart\u00edn A, Fern\u00e1ndez-Alvarez C, Narzisi A, Garc\u00eda-Primo P, Kawa R, Posada M, Canal-Bedia R. Early detection and intervention of ASD: a European overview. Brain Sci. 2017;7(12):159.","journal-title":"Brain Sci"},{"issue":"1","key":"1064_CR110","doi-asserted-by":"publisher","first-page":"e012836","DOI":"10.1136\/bmjopen-2016-012836","volume":"7","author":"AM Wurtz","year":"2017","unstructured":"Wurtz AM, Rytter D, Vestergaard CH, Christensen J, Vestergaard M, Bech BH. Prenatal exposure to antiepileptic drugs and use of primary healthcare during childhood: a population-based cohort study in Denmark. BMJ Open. 2017;7(1):e012836. https:\/\/doi.org\/10.1136\/bmjopen-2016-012836 .","journal-title":"BMJ Open"},{"key":"1064_CR111","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/infdis\/160.1.83","volume":"160","author":"DW Teele","year":"1989","unstructured":"Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis. 1989;160:83\u201394.","journal-title":"J Infect Dis"},{"issue":"4","key":"1064_CR112","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s11845-018-1757-6","volume":"187","author":"H Mohd Yunos","year":"2018","unstructured":"Mohd Yunos H, Green A. Fetal valproate syndrome: the Irish experience. Ir J Med Sci. 2018;187(4):965\u20138.","journal-title":"Ir J Med Sci"},{"key":"1064_CR113","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41439-018-0019-5","volume":"5","author":"T Yokoi","year":"2018","unstructured":"Yokoi T, Enomoto Y, Tsurusaki Y, Naruto T, Kurosawa K. Nonsyndromic intellectual disability with novel heterozygous SCN2A mutation and epilepsy. Hum Genome Var. 2018;5:20.","journal-title":"Hum Genome Var"},{"issue":"5","key":"1064_CR114","first-page":"83","volume":"42","author":"S Koch","year":"1992","unstructured":"Koch S, Losche G, Jager-Roman E, et al. Major and minor birth malformations and antiepileptic drugs. Neurology. 1992;42(5):83\u20138.","journal-title":"Neurology."},{"issue":"4","key":"1064_CR115","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/cpt.158","volume":"98","author":"M Tanoshima","year":"2015","unstructured":"Tanoshima M, Kobayshi T, Tanoshima R, Beyene J, Koren G. Risks of congenital malformations in offspring exposed to valproic acid in utero; a systematic review and cumulative meta-analysis. Clin Pharmacol Ther. 2015;98(4):417\u201341.","journal-title":"Clin Pharmacol Ther"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1064-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1064-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1064-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T05:59:05Z","timestamp":1721541545000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1064-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,19]]},"references-count":115,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1064"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1064-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,19]]},"assertion":[{"value":"19 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This project was only possible through a multidisciplinary approach. JCS, PT and JD are clinical geneticists with a long term interest in teratogenic effects of antiepileptic drugs. RB is a clinical psychologist and AW a developmental neuropsychologist with extensive clinical and research interests in this area. RD is a general practitioner looking after children and adults with learning disability in primary care. RD also has experience in dysmorphology and clinical genetics. VC is a senior physiotherapist who runs a specialist clinic for children with joint hypermobility. HM has a background in teratology and LB is a consultant paediatrician with a special interest in neural tube defects. GJ is a craniofacial surgeon who works in a specialist craniosynostosis team and IB is an academic ENT surgeon. RW is a consultant anaesthetist and AJ is a junior medical doctor who has undertaken previous research studies on the clinical and genetic aspects of Fetal Valproate Syndrome. CD is a speech and language therapist attached to one of the UK Cleft Networks and working in the community. LH and NA are child and adolescent psychiatrists, LH has a specific interest in autism spectrum disorder. JA is a paediatric ophthalmologist and DH is a consultant paediatrician with a special interest in neurodisability. SS is a clinical fellow in paediatric nephrology. GAD is a consultant neonatologist with a specific interest in congenital malformations and dysmorphology. EL is a paediatric cardiologist who has published in this area previously, MR is a research associate who works as data manager for the European Reference Network ERN ITHACA. This project came out of initial work by HJ and SO, clinical geneticists who prepared the French protocol for diagnosis and care on Fetal Valproate Syndrome. Finally, a very important contribution to this group came from JW who is a parent and coordinates a support group for families who have children affected by teratogenic effects of antiepileptic drugs.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"Ethics approval was not required for the purpose of drawing up these management recommendations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Signed consent for publication of the accompanying patient images was obtained from all of the patients concerned. Copies of consent forms available on request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All participants in the process were asked to declare any conflicts of interest or competing interests. The authors declared that they had no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"180"}}